GD Lifescience
Timeline
12 events since 2019Filings
Financial
Establishments
2020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 37 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0728464654
2025
Highest result from 2020 to 2025 net €504,187 ▲77.3% The operating result of €694,208 and the net result of €504,187 are both a record.
Annual accounts 2024 filed PDFmicro format · 7 days before the deadline
2024
Equity above €500,000 equity €523,572 ▲119% Equity rises from €239,191 to €523,572.
Annual accounts 2023 filed PDFmicro format · 30 days before the deadline
2023
Annual accounts 2022 filed PDFmicro format · 39 days before the deadline
2022
Annual accounts 2021 filed PDFmicro format · 39 days before the deadline
2021
Equity above €200,000 equity €271,236 ▲66.2% With a profit in every financial year since 2020, equity grows to €271,236.
Annual accounts 2020 filed PDFmicro format · 16 days before the deadline
2019
IncorporationFounding capital of €20,000, 200 shares · Founders: (comparant) and (comparant) · Appointments: (director) and (director) · published on 17-06-20197 points ▸
- Founder, (comparant)
- Founder, (comparant)
- Founding capital, €20,000, 200 shares
- Registered office clause, Narcissenlaan 8, 3090 Overijse
- Board rule, 2
- Director appointment, (director (not named in the articles))
- Director appointment, (director (not named in the articles))
- The deed holds 5 more points.
First establishment Narcissenlaan 8, Overijse
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank